LIN Form 4: Director Stephen Angel Exercises Options and Disposes Shares
Rhea-AI Filing Summary
Linde plc (LIN) director Stephen F. Angel reported option exercise and share sales on 08/07/2025. The filing shows the acquisition of 125,000 ordinary shares via exercise and contemporaneous dispositions of 74,691 and 50,309 shares at weighted average sale prices reported as $474.94 and $473.38, respectively. The exercise price reported for the transactions is $118.71. The Form 4 lists aggregate post-transaction beneficial ownership totals shown as 605,542.502 shares (direct) and additional indirect holdings held in descendants' trusts, a 401(k) account and deferred share units. The filing is signed by an attorney-in-fact on 08/08/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR: Director exercised options for 125,000 shares and sold portions at about $474, showing routine tax/covering activity, not a material corporate change.
The Form 4 documents an option exercise resulting in 125,000 ordinary shares acquired at a reported exercise price of $118.71. The director sold 74,691 and 50,309 shares with weighted average sale prices of $474.94 and $473.38, respectively, and the filer explains shares were withheld to cover exercise price and tax withholdings. From an investor-impact perspective, these are insider liquidity and tax-related transactions rather than signals of corporate operational change; they do not alter outstanding option schedules or indicate new financing events.
TL;DR: Routine director reporting: sizable option exercise, partial dispositions, and disclosure of indirect holdings and deferred units; governance controls appear followed.
The filing identifies Stephen F. Angel as a Director and discloses multiple forms of compensation-related holdings including restricted stock units, deferred stock units and several outstanding stock option grants with exercise and expiration details listed. The submission includes explicit explanations for withholding and sale price ranges and is signed by an attorney-in-fact, indicating adherence to reporting procedures. This disclosure is standard for compensatory equity activity and raises no governance red flags in the document itself.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options (right to buy) | 125,000 | $0.00 | -- |
| Exercise | Ordinary Shares | 125,000 | $118.71 | $14.84M |
| Tax Withholding | Ordinary Shares | 74,691 | $474.94 | $35.47M |
| Sale | Ordinary Shares | 50,309 | $473.38 | $23.82M |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Deferred Stock Units | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- Ordinary shares withheld to cover exercise price and tax withholdings. The price reported is the weighted average sale price. The sale prices ranged from $471.39 to $474.62. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. The Restricted Stock Unit ("RSU") shall vest in full and payout in Ordinary Shares on a one-for-one basis one year after the March 7, 2025 date of grant, provided that the awardee serves on the Linde plc Board of Directors continuously through the vesting date, except under certain circumstances in which a pro-rata payout may be made. Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis. Restricted Stock Units that have vested in full but whose payout has been deferred to a future date. Restricted Stock Units granted March 20, 2019, that have vested in full but whose payout has been deferred to a future date. Restricted Stock Units granted February 27, 2018, that have vested in full but whose payout has been deferred to a future date. Restricted Stock Unit award granted February 28, 2017, that has vested in full but whose payout has been deferred to a future date. Restricted Stock Units granted February 28, 2017, that have vested in full but whose payout has been deferred to a future date. Restricted Stock Unit award granted February 23, 2016, that has vested in full but whose payout has been deferred to a future date. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021. This option vests over three years in three consecutive equal annual installments beginning on March 20, 2020. This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis Deferred Stock Units acquired under the Linde Compensation Deferral Plan that will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Deferral Plan.
